chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a booster shot, Pfizer, on Aug 29 and on Sept 11 started having severe and depilating headaches with nausea, to the extreme that I went to a Neurologist who prescribed a MRI/MRA on Oct 11. My MRI showed bleeding in my brain and 2 mini strokes. Also, shortly after the shot, I developed an area on my arm that has continually been unbearably itchy and warm to the touch with a tingly pain to date. There is no relief even with taking an antihistamine or using cortisone products. it is approximately 3 inches above my wrist to approximately 1 inch below the elbow crease of my right arm. My shot was in the left arm.
This spontaneous report was received from a registered nurse refers to a 16 month old male patient. On 04-DEC-2012(reported as today), the patient was vaccinated with a dose of 0.5 ml PROQUAD (Merck),(lot number, expiration date and route not reported) on the right arm. On the same day the patient was also administered with a dose of MMR II,(lot number, expiration date and route not reported) in the left arm. Concomitant medications included PREVNAR 13 and PEDIARIX which were also administered on 04-DEC-2012. No adverse effects were reported. It was unspecified if the patient had sought medial attention. Additional information is not expected.
Information has been received from a nurse referring to a 60 year old female patient. No concurrent or historical conditions were reported. On 14-JUL-2015 the patient was vaccinated with (Oka/Merck) VARIVAX (lot # L000453, expiration date 06-JAN-2017), strength reported as "1350 U", subcutaneously in the left arm, instead of ZOSTAVAX. The patient stated that the error was not a result of medication confusion. The patient was indicated to received ZOSTAVAX. The patient had not experienced any adverse effects. Additional information has been requested.
Patient received vaccination on Day 9 from symptom onset of COVID-19 disease after discharge from hospital. No adverse reactions at this time.
Pt recvd TD 8OCT91, had soreness in rt arm @ inject site 9OCT91; On 10OCT91 approx 330PM had temp 101 that continued thoughout the day along w/sore, scratchy throat; On 11OCT91 noticed rash on rt arm @ inject site; Seen by MD;
Information has been received from a consumer concerning her 24-month-old daughter who on 25-MAR-2006 was vaccinated with a dose of Varivax (Oka/Merck). On 28-MAR-2006 the patient experienced varicella lesions on her chest, trunk, and extremities. No other information was provided. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Mom called on 1/20/23 @ 9:39am & spoke with myself @ 11:13am mom reported 15 min after vaccine pt got a metallic taste in mouth & 30min after that pt had headache & severe stomach pain. 1 hour pt had nausea/vomiting/diarrhea x1 hour. Pt. went to sleep. 6 hrs later pt felt like throat was tight & sore. Mother spoke with MD on call and was told to avoid nasal influenza in the future. for SOB & hives. Mom reported on 1/20/23 that pt stil w/ some tightness/sore feeling in throat & gave pt Benadryl prior to going to school.
No immediate symptoms until waking up the next morning. There were no changes in diet, exercise, or hydration that would otherwise explain the headache.  There has been a dull aching from site of injection up through shoulder and into base of the head throughout the course of the day after the vaccination
Pt recvd 3 doses of Engerix-B vax 01JUN90, 11JUL90 & 20DEC90 & it was determined that pt did not seroconvert;
Pt developed red itchy bumpy skin condition at vaccination site. MD thought it might be cellulitis, prescribed amoxicillin.
9/28/12 Pt developed facial swelling, runny eyes, swollen eyes, and a "funny sensation" to her nose after received Dtap, IPOL, MMR vaccines. Went to ER. 10/1/12 Later in day - mom reports (L) upper arm swelling, redness, pain 2" x 2" = cellulitis per walk in MD.
Pfizer 9/17/21, 10/9/21. Positive on 10/1/22
Itches a little; Red dots on injection Site; Pain and tenderness at injection site; A spontaneous report was received from a dental hygienist, who was  a 53-year-old, female patient who experienced vaccination site pain, vaccination site erythema and vaccination site pruritus.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 26-Dec-2020, the patient received their first of two planned doses of mRNA-1273 (Lot number 039K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   The patient reported that she received her first shot of the Moderna Covid-19 Vaccine on 26-Dec-2020 and went through the normal side effects of pain and tenderness in the injection site. These events resolved. On 02-Jan-2021, she observed red dots on the injection site. The next day, 03-Jan-2021, she reported that the red dots were connected and that the red area looked a "little bigger than a golf ball" (about 2.5") on the injection site. The patient reported that it itched, but not much. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the event, vaccination site pain, was considered recovered/resolved. The outcome of the events, vaccination site erythema and vaccination site pruritus, were considered unknown.; Reporter's Comments: This case concerns a 53-year-old female who had nonserious expected event of vaccination site erythema, vaccination site pain, vaccination site pruritus.  Event onset the same day as the first dose of mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the vaccination site erythema, vaccination site pain, vaccination site pruritus, a causal relationship cannot be excluded.
Skin rash in ejection area. Area about two inches red itching and hot to the touch. No soreness or pain.
Two blisters that itched and drained.  One on each forearm, rash on abdomen, open sore in right nostril, open sore on L & R bottom lip, open sore on vulva.  Mucous membranes seem to be affected.  Patient has not had of these conditions previously, prior to receiving the COVID 19 vaccine.
Information was received on 03-MAY-2017 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 03-SEP-2014 the patient received the ZOSTAVAX(lot number and expiration not reported) subcutaneous for its intended purpose of the prevention of shingles. On 20-MAR-2015, the patient went to a physician for complaints of fatigue, dizziness, body aches, and headaches. The patient was diagnosed with Bell's palsy. The patient's condition developed into paralysis on the right side of her face and ringing in her ear. It was reported that the patient's injuries were caused by the ZOSTAVAX. The patient was never told, and never had any reason to believe, that her injuries were related in any way to the ZOSTAVAX vaccine until recently. The patient suffered nerve damage and continues to suffer from Bell's palsy. As a direct and proximate result of the ZOSTAVAX vaccine the patient's symptoms have resulted in physical limitations not present prior to her use of the ZOSTAVAX vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the patient's use of ZOSTAVAX, the patient has suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of her use of ZOSTAVAX vaccine. Bell's Palsy/paralysis on the right side of her face was considered to be medically significant. Bell's Palsy/paralysis on the right side of her face, ringing in her ear, fatigue, dizziness, body aches, headaches and nerve damage were considered to be disabling.  Additional information has been requested.
3/30/2021, the day of vaccination, patient experienced fever and arm tenderness. Evening, the next day, 3/31, patient had chills and felt "cold inside". She has continued to feel cold inside for next 3 weeks. Has also experienced fatigue, nausea, and headache off and on. Follows a pattern of being worse overnight and in the morning, and then feeling okay by evening, and then repeats the next day.  On 4/20 her physician advised her to wait to receive the second dose until she felt better. Her next doctor appt is June 3. On  4/23 she felt almost normal but still felt a bit cold inside with slight headache. On 5/7 she feels almost completely normal with a slight coldness by her eyebrows each night. She feels well enough now to come for her second vaccine dose next week.
Intermittent tachycardia (120-150s) and hypertension (176/114) for about an hour. Had labs drawn and received NS IV fluids. Upon discharge, persistent headache, left axillary lymph node pain, and fatigue.
Narrative:  Patient reported experiencing cough, extreme fatigue that subsided after 2-3 days post vaccination
felt tired on right arm; headaches in the morning for the last 1.5 weeks; arm is itchy for 1 week; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (felt tired on right arm), VACCINATION SITE PRURITUS (arm is itchy for 1 week) and HEADACHE (headaches in the morning for the last 1.5 weeks) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (arm is itchy for 1 week). On 17-Mar-2021, the patient experienced HEADACHE (headaches in the morning for the last 1.5 weeks). On 29-Mar-2021, the patient experienced LIMB DISCOMFORT (felt tired on right arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 06-Mar-2021, VACCINATION SITE PRURITUS (arm is itchy for 1 week) had resolved. At the time of the report, LIMB DISCOMFORT (felt tired on right arm) and HEADACHE (headaches in the morning for the last 1.5 weeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 100 (High) 100 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Approximately 7 hours later noticed a pear shape, light pink lump about a third of the way down outer arm from the injection site.  About 24 hours later noticed the lump was gone and there was a pink, slightly swollen area about 6 inches above elbow joint and saggy skin from that point under arm to about 4 inches below the elbow.  Would wiggle back and forth when I shook arm.  No pain and no other unusual symptoms.
Information has been received from healthcare worker concerning an unspecified number of patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On unknown dates, the patients received unspecified improperly stored doses of PROQUAD (Merck) (strength, frequency and route unknown), Lot# L010143 with Exp. date 24-SEP-2016, Lot# L005296 with Exp. date 17-AUG-2016, and therapy type HSA). The vaccines were exposed to 30.9F for 11 hours 50 minutes at first excursion; and then exposed to 9 F for 3 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Shot was given high on arm, top of shoulder. Very painful injection. Next day developed Shingles on left backside
Near Fainting and stiff neck.  He was assisted from the chair to the bed and laid down. Vitals monitored for 30 min. No other complaints or reactions.  Alert entire time and related to feeling much better after water and the time monitored.  He did not want any further assistance and left under his own ability.
Heart racing, feeling as though her throat was closing, vital signs normal, clear lung sounds, PT drinking well, talking without difficulty
PATIENT DECEASED ON 01/16/18 (POSSIBLE SIDS) UNDER INVESTIGATION.
I went on a Skiing trip in March 2022 and got into a really bad ski accident. Five days later after the accident I noticed my arm was really black so I went to the ER and they found blood clots, I was prescribed blood thinner shots and aspirin. I've been out of the hospital for about a month and trying to recover. I believe the blood clots were due to the vaccine and not the accident because I have a history of a healthy lifestyle and the blood clots didn't tie into my accident.
This vaccine, which is recommended for children ages 4-6, was mistakenly given to a 4 month old. This is not the age-appropriate immunization. She was supposed to be given the second dose of her DTap (INFANRIX).
1 of 3 pts vaxed from the same vial who exp a localized, erythematous rash @ inject site w/in 24-48 hrs p/immun; site of react approx 7-8cm; treated w/DPH; pt recovered;
Hair has been falling out; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  An 88-year-old female patient received BNT162b2 (BNT162B2), on 22Nov2021 as dose 3 (booster), single (Lot number: FG3524) at the age of 88 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing). The patient's medical history, reported also as family history included: "high blood pressure" (unspecified if ongoing), notes: Been taking blood pressure medicine for years and never had any problems.; "Cancer" (unspecified if ongoing), notes: Cancer in her family and high blood pressure and thyroid. The patient's concomitant medications were not reported. Vaccination history included: pfizer covid vaccine (DOSE 1, Single, Lot number: EW0169, Expiration is unknown, Anatomical site: Injected in left arm), administration date: 14May2021, when the patient was 88-year-old, for COVID-19 immunization; pfizer covid vaccine (DOSE 2, Single, Lot number: EW01S3, Anatomical site: Injected in left arm, she said she cannot make it out.), administration date: 04Jun2021, when the patient was 88-year-old, for COVID-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset Nov2021, outcome "not recovered", described as "Hair has been falling out". Therapeutic measures were taken as a result of alopecia.  Additional information: Hair has been falling out was reported as worsened. No other Conditions. Received a call from consumer regarding booster shot 3rd one of Pfizer and reported her hair has been falling out. Within a week of getting the third booster shot is when she started noticing it. Just shampooed it and it comes out in her hands. No medical treatment. Just treated herself with oils and things to strengthen it and special shampoos and it just keeps breaking. She knows a lot of people are going through the same thing. No prior vaccinations taken (within 4 weeks). Time: morning. Vaccine was not administered at Facility. Vaccination Facility Type was Pharmacy. The patient had vaccine on 03Oct2022, Batch/lot number GH9703, Dosage text was Unknown dose injected in left arm.
Increased heart rate; Increased blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Increased heart rate) and BLOOD PRESSURE INCREASED (Increased blood pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 011A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced HEART RATE INCREASED (Increased heart rate) and BLOOD PRESSURE INCREASED (Increased blood pressure). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 81 mg. At the time of the report, HEART RATE INCREASED (Increased heart rate) and BLOOD PRESSURE INCREASED (Increased blood pressure) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Blood pressure measurement: 130 (High) High and 135 (High) High. On 29-Mar-2021, Electrocardiogram: normal (normal) Normal. On 29-Mar-2021, Heart rate: 90 beats per minute (High) High.         Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up received contains significant information including outcome of event and lab test.
went from not feeling well to barfing and pooping blood organs shutting  down suddenly dropping dead
Patient received 1st dose of Shingrix vaccine on Friday 12/14/18. Patient stated that the next morning she had a rash on her arms and extending to her trunk. The patient does not fully remember details of its appearance but stated it was very itchy and made her quite uncomfortable. She then noticed some swelling in her fingers and lips/face Sunday 12/16/18 afternoon extending into the evening. She stated she noticed it in her hands first but then said her cheeks looked a little puffy. She stated there was also some itching/tingling around her lips that Sunday evening. She took a Benadryl tablet and went to bed, and both the swelling and rash seemed to resolve over the next day. Patient stated that she feels her fingers might still be a little swollen, but denies any discomfort.
Initial report received on 01 October 2008 from a nurse.  A 32-year-old male patient, who has past medical history of asthma, had received a first dose of YF VAX (Lot # UF307AB) on 01 October 2008.  The route and site of administration were not reported.  Approximately 20 minutes post-vaccination, the patient experienced throat swelling, nausea, burning sensation of ears, redness of the face, chest, back and hands.  The patient required medical evaluation and was treated with SOLU-MEDROL, BENADRYL and "ZOPHRAN."  Treatment medication routes were not provided.  Per the reporter, no diagnostic testing's were performed.  At an unspecified amount of time later, on 01 October 2008, the patient's symptoms resolved.
It was extreme rash with hives and itching. It started with both arms the eventually went to the legs and lasted 6 weeks. The healthcare provider I saw prescribed me topicals and ointments which didn't do much to alleviate the rash.
Global amnesia. This case was reported by a physician and described the occurrence of transient global amnesia in a 61 year old male subject who was vaccinated with influenza vaccine trivalent (FLULVAL, Glaxosmithkline). Concurrent medical conditions included diabetes, elevated cholesterol and high blood pressure. Concurrent medications included Diabetes medication, Blood pressure medication and Anti-hypercholesterolaemic (cholesterol reducing agent). On September 2009 the subject received unspecified dose of FLULAVAL (unknown, left arm). On September 30, 2009, 1 day after vaccination with FLULAVAL, the subject experienced transient global amnesia. On 30 September 2009, the event was resolved. The physician considered the transient global amnesia was unrelated to vaccination with FLULAVAL.
On November 27, at approximately 2:30 in the afternoon, the patients body temperature/ fever went up to 104. 5. We gave her a cool bath, then some tylenol.   It came down. The following evening it shot back up, and ibuprfen was given. The evening of 11/27 I contacted the hospital where the vaccine was administered and asked them to fill this form out, they told me I could do it on line. She also developed flu like symptoms. A cough and runny nose.
Scabs, sweats, headache, nausea. swollen jaw.  Pt treated herself at home with ibuporphen and imetrex.
hot around the ears; lymph nodes were swollen and it went under her arm pit and breast area; uncomfortable to lift her arm; woke up with a racing heart beat of about 153 bpm; fever; racing heart beat; light headed; Dizzy; felt like she couldn't stand; soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (racing heart beat), DIZZINESS (light headed), DIZZINESS (Dizzy), DYSSTASIA (felt like she couldn't stand) and PAIN IN EXTREMITY (soreness in the arm) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HEART RATE INCREASED (racing heart beat), DIZZINESS (light headed), DIZZINESS (Dizzy), DYSSTASIA (felt like she couldn't stand), PAIN IN EXTREMITY (soreness in the arm) and PYREXIA (fever). On 05-Mar-2021, the patient experienced HEART RATE INCREASED (woke up with a racing heart beat of about 153 bpm). On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (uncomfortable to lift her arm) and LYMPHADENOPATHY (lymph nodes were swollen and it went under her arm pit and breast area). On an unknown date, the patient experienced FEELING HOT (hot around the ears). On 04-Mar-2021, HEART RATE INCREASED (racing heart beat), DIZZINESS (light headed) and DIZZINESS (Dizzy) had resolved. On 12-Mar-2021, PAIN IN EXTREMITY (uncomfortable to lift her arm) and LYMPHADENOPATHY (lymph nodes were swollen and it went under her arm pit and breast area) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (soreness in the arm) and HEART RATE INCREASED (woke up with a racing heart beat of about 153 bpm) had resolved and FEELING HOT (hot around the ears) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment drugs include: Advil and Tylenol patient just finished up a 2 wk prescription for an antibiotic